Onconetix sets November 6 date for 1-for-10 reverse stock split
Onconetix will carry out a 1-for-10 reverse split effective November 6, 2026, lifting its total ratio to 1-for-100. ONCO stays listed on Nasdaq.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, Onconetix has set November 6, 2026 as the effective date for a 1-for-10 reverse split of its shares. The change begins at 12:01 a.m. Eastern Time that day and brings the company's combined reverse split ratio to 1-for-100.
The number of outstanding shares is expected to fall from about 5.9 million to roughly 589,000, before adjustments for fractional shares. Authorized common stock remains at 250 million shares, and the par value stays at $0.00001 per share. No fractional shares will be issued; holders will receive cash instead, while equity awards and other securities will be adjusted proportionally. Trading will continue on Nasdaq under the existing ticker ONCO.
why it matters
A reverse split on its own does not change an investor's stake, since the share count and share price adjust in the same proportion. The news matters mainly to ONCO holders and those following this company's corporate actions, so its impact on the broader market is limited.
tags
instruments
sources
- Onconetix Sets Nov. 6 Effective Date for 1-for-10 Reverse Stock Split — TradingView, 26 October 2026 at 21:13 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗